SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 25.93 |
| Enterprise Value ($M) | 29.56 |
| Book Value ($M) | -8.86 |
| Book Value / Share | -1.03 |
| Price / Book | -2.93 |
| NCAV ($M) | -20.04 |
| NCAV / Share | -2.33 |
| Price / NCAV | -1.29 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.29 |
| Return on Assets (ROA) | -0.87 |
| Return on Equity (ROE) | -9.24 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.56 |
| Current Ratio | 1.57 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 16.16 |
| Assets | 27.34 |
| Liabilities | 36.19 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.34 |
| Operating Income | -33.09 |
| Net Income | -39.40 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -21.33 |
| Cash from Investing | 6.32 |
| Cash from Financing | -1.53 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | -40.13 | |
| 13G/A | AWM Investment Company, Inc. | 5.70 | -96.06 | |
| 13G/A | Mosca Alison | 19.70 | 94.89 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,420 | 15,126 | 22.61 | |
| 17,343 | 57,042 | 30.40 | |
| 3,855 | 17,419 | 22.13 | |
| 7,433 | 31,166 | 23.85 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CING – Cingulate Inc. | CKPT – Checkpoint Therapeutics, Inc. |
| CLDX – Celldex Therapeutics, Inc. | CLRB – Cellectar Biosciences, Inc. |
| CMPX – Compass Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io